⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL667571 | 1.00 | — | — | |
| SCHEMBL31520043 | 1.00 | — | — | |
| SCHEMBL4037202 | 1.00 | — | — | |
| SCHEMBL9512745 | 1.00 | — | — | |
| SCHEMBL31520046 | 1.00 | — | — | |
| SCHEMBL5844291 | 0.97 | GABRR1 (0.94) | — | |
| SCHEMBL24293602 | 0.83 | GABRR1 (0.70) | — | |
| SCHEMBL4858169 | 0.81 | — | — | |
| SCHEMBL5028910 | 0.81 | — | — | |
| SCHEMBL17234168 | 0.81 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117645550-A | Fatty acid amide cyclopropane carboxylate and preparation method thereof | 成都科宏达化学有限责任公司 | 2024-03-05 | — | — | CN | claimed |
| US-20210069134-A1 | COMPOSITIONS AND METHODS OF TREATING A SUBJECT WITH TAURINE AND DERIVATIVES THEREOF | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK | 2021-03-11 | — | — | US | claimed |
| JP-5155827-A | — | — | None | — | — | JP | disclosed |
| JP-5155827-A | — | — | None | — | — | JP | disclosed |
| EP-4719381-A1 | LIGAND-POLAR DRUG CONJUGATES | Tripartite Therapeutics Inc. (TW) | 2026-04-08 | — | — | EP | disclosed |
| US-20250163052-A1 | cGAS INHIBITORS AND USES THEREOF | CORNELL UNIVERSITY | 2025-05-22 | — | — | US | disclosed |
| US-20250032635-A1 | LIGAND-POLAR DRUG CONJUGATES | TRIPARTITE THERAPEUTICS INC. (TW) | 2025-01-30 | — | — | US | disclosed |
| EP-4479134-A1 | CGAS INHIBITORS AND USES THEREOF | Cornell University (US) | 2024-12-25 | — | — | EP | disclosed |
| CN-119060927-A | Engineering strain and application thereof in fermentation production of L-aminocyclopropane-2-carboxylic acid | 中国科学院微生物研究所 | 2024-12-03 | — | — | CN | disclosed |
| CN-119060927-A | Engineering strain and application thereof in fermentation production of L-aminocyclopropane-2-carboxylic acid | 中国科学院微生物研究所 | 2024-12-03 | — | — | CN | disclosed |
| EP-4373817-A1 | SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER | Astrazeneca AB (SE) | 2024-05-29 | — | — | EP | disclosed |
| US-20060122107-A1 | Method of modulating cellular activity and molecules for use therein | MONASH UNIVERSITY (AU) | 2006-06-08 | — | — | US | disclosed |
| US-20060039974-A1 | Sustained release preparation | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-02-23 | — | — | US | disclosed |
| EP-1549335-A1 | A METHOD OF MODULATING CELLULAR ACTIVITY AND MOLECULES FOR USE THEREIN | MONASH UNIVERSITY (AU) | 2005-07-06 | — | — | EP | disclosed |
| EP-1537880-A1 | SUSTAINED RELEASE PREPARATION | Takeda Pharmaceutical Company Limited (JP) | 2005-06-08 | — | — | EP | disclosed |
| WO-2004022582-A1 | PEPTIDOMIMETIC DRUGS | MONASH UNIVERSITY (AU) | 2004-03-18 | — | — | WO | disclosed |
| WO-2004022084-A1 | A METHOD OF MODULATING CELLULAR ACTIVITY AND MOLECULES FOR USE THEREIN | MONASH UNIVERSITY (AU) | 2004-03-18 | — | — | WO | disclosed |
| EP-1137667-A2 | ANALOGUES OF GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES S.A.S. (FR) | 2001-10-04 | — | — | EP | disclosed |
| WO-2000034331-A2 | ANALOGUES OF GLP-1 | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES SAS (FR) | 2000-06-15 | — | — | WO | disclosed |
| JP-H05155827-A | PRODUCTION OF CIS-2-AMINOCYCLOPROPANECARBOXYLIC ACID DERIVATIVE | BANYU PHARMACEUT CO LTD | 1993-06-22 | — | — | JP | disclosed |